07.02.2013 Views

Bulletin 2011/50 - European Patent Office

Bulletin 2011/50 - European Patent Office

Bulletin 2011/50 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(2)<br />

Zhang, Zhenxi, Cambridge MA 02140, US<br />

Lei, Wende, Cambridge MA 02140, US<br />

Monath, Thomas P., Harvard MA 014<strong>50</strong>, US<br />

(74) Zwicker, Jörk, et al, Dr. Volker Vossius<br />

<strong>Patent</strong>- und Rechtsanwaltskanzlei Geibelstrasse<br />

6, 81679 München, DE<br />

(62) 04814456.2 / 1 708 743<br />

A61K 39/08 → (51) A61K 39/02<br />

A61K 39/095 → (51) C07K 14/22<br />

(51) A61K 39/395 (11) 2 394 659 A1<br />

A61K 35/14 A61K 31/56<br />

A61K 31/138 G01N 33/96<br />

C07K 16/06 G01N 33/577<br />

G01N 33/574 G01N 33/74<br />

G01N 33/68 G01N 33/<strong>50</strong><br />

C07K 14/72 A61P 35/00<br />

(25) En (26) En<br />

(21) 10184646.7 (22) 10.05.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(30) 10.05.2000 US 203314 P<br />

31.05.2000 US 208348 P<br />

31.05.2000 US 208111 P<br />

30.08.2000 US 229071 P<br />

08.09.2000 US 231273 P<br />

(54) • Mittel und Methoden zur Demonstration<br />

der sekretorischen Immunsystem- Regulierung<br />

von auf Steroid Hormon reagierende<br />

Krebszellen<br />

• Compositions and methods for demonstrating<br />

secretory immune system regulation<br />

of steroid hormone responsive cancer<br />

cell growth<br />

• Compositions et procédés pour le diagnostic,<br />

le traitement et la prévention des<br />

cancers répondant à l'hormone de croissance<br />

(71) Signe BioPharma Inc., 1717 W Walnut Hill<br />

Lane, Suite 104, Irving TX 7<strong>50</strong>38, US<br />

(72) Sirbasku, David A., Flower Mound, TX<br />

7<strong>50</strong>28, US<br />

(74) Chapman, Paul Gilmour, Marks & Clerk LLP<br />

Aurora 120 Bothwell Street, Glasgow G2<br />

7JS, GB<br />

(62) 01948216.5 / 1 328 293<br />

(51) A61K 39/395 (11) 2 394 660 A1<br />

A61K 35/14 A61K 31/56<br />

A61K 31/138 G01N 33/96<br />

C07K 16/06 G01N 33/577<br />

G01N 33/574 G01N 33/74<br />

G01N 33/68 G01N 33/<strong>50</strong><br />

C07K 14/72 A61P 35/00<br />

(25) En (26) En<br />

(21) 1018<strong>50</strong>03.0 (22) 10.05.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

AL LT LV MK RO SI<br />

(30) 10.05.2000 US 203314 P<br />

31.05.2000 US 208348 P<br />

31.05.2000 US 208111 P<br />

30.08.2000 US 229071 P<br />

08.09.2000 US 231273 P<br />

(54) • Mittel und Methoden zur Demonstration<br />

der sekretorischen Immunsystem-Regulierung<br />

von auf Steroidhormon reagierenden<br />

Krebszellen<br />

• Compositions and methods for the diagnosis,<br />

treatment and prevention of steroid<br />

hormone responsive cancers<br />

• Compositions et procédés pour le diagnostic,<br />

le traitement et la prévention des<br />

cancers répondant à l'hormone de croissance<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(71) Signe BioPharma Inc., 1717 W Walnut Hill<br />

Lane, Suite 104, Irving TX 7<strong>50</strong>38, US<br />

(72) Sirbasku, David A., Flower Mound, TX<br />

7<strong>50</strong>28, US<br />

(74) Chapman, Paul Gilmour, Marks & Clerk LLP<br />

Aurora 120 Bothwell Street, Glasgow G2<br />

7JS, GB<br />

(62) 01952116.0 / 1 366 366<br />

(51) A61K 39/395 (11) 2 394 661 A1<br />

A61P 25/00 C07K 16/18<br />

C07K 16/28 C12N 15/113<br />

(25) En (26) En<br />

(21) 11178521.8 (22) 07.07.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK RS<br />

(30) 08.07.2005 US 697336 P<br />

10.02.2006 US 771900 P<br />

19.06.2006 US 814522 P<br />

(54) • Sp35-Antikörper und Verwendungen dafür<br />

• Sp35 antibodies and uses thereof<br />

• Anticorps Sp35 et utilisations associées<br />

(71) Biogen Idec MA Inc., 14 Cambridge Center,<br />

Cambridge, Massachusetts 02142, US<br />

(72) Mi, Sha, Belmont, MA 02478, US<br />

Pepinsky, R. Blake, Arlington, MA 02474, US<br />

Shao, Zhaohui, Brookline, MA 02466, US<br />

Graff, Christilyn P., Cambridge, MA 02139,<br />

US<br />

(74) Miller, David James, Mathys & Squire LLP<br />

120 Holborn, London EC1N 2SQ, GB<br />

(62) 06786428.0 / 1 904 104<br />

(51) A61K 39/395 (11) 2 394 662 A2<br />

G01N 33/53 C12N 5/20<br />

C07K 16/28<br />

(25) En (26) En<br />

(21) 11180077.7 (22) 30.03.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(30) 02.04.2004 US 559175 P<br />

(54) • Verfahren und Zusammensetzungen für die<br />

Behandlung und Vorbeugung von mit<br />

alpha v beta 5-integrin assoziierten Krankheiten<br />

• Methods and compositions for treating and<br />

preventing disease associated with<br />

AlphavBeta5 intergrin<br />

• Compositions et méthodes de traitement et<br />

de prevention d'une maladie associée a<br />

l'integrine alpha v beta 5<br />

(71) The Regents of The University of California,<br />

12th Floor 1111 Franklin Street, Oakland, CA<br />

94607-5200, US<br />

(72) Sheppard, Dean, Oakland, CA California<br />

94610, US<br />

Atakilit, Amha, Hayward, CA California<br />

94544, US<br />

(74) Campbell, Patrick John Henry, J.A. Kemp &<br />

Co. 14 South Square Gray's Inn, London<br />

WC1R 5JJ, GB<br />

(62) 05763460.2 / 1 734 996<br />

A61K 39/395 → (51) A61K 31/541<br />

A61K 39/395 → (51) A61K 38/02<br />

A61K 39/395 → (51) C07K 16/18<br />

A61K 39/395 → (51) C07K 16/24<br />

A61K 39/395 → (51) C07K 16/28<br />

186<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>50</strong>/<strong>2011</strong>) 14.12.<strong>2011</strong><br />

A61K 39/395 → (51) C07K 16/46<br />

A61K 39/395 → (51) C12P 21/02<br />

A61K 39/40 → (51) C07K 16/12<br />

A61K 41/00 → (51) C07K 16/28<br />

A61K 45/00 → (51) A61K 38/02<br />

A61K 45/06 → (51) A61K 31/337<br />

A61K 47/00 → (51) A61K 38/02<br />

A61K 47/06 → (51) A61K 31/58<br />

A61K 47/10 → (51) A61K 31/439<br />

A61K 47/10 → (51) A61K 31/58<br />

A61K 47/10 → (51) A61K 38/26<br />

A61K 47/14 → (51) A61K 9/00<br />

A61K 47/18 → (51) A61K 38/26<br />

A61K 47/20 → (51) A61K 38/26<br />

A61K 47/26 → (51) A61K 31/439<br />

A61K 47/26 → (51) A61K 38/26<br />

A61K 47/32 → (51) A61K 31/439<br />

(51) A61K 47/34 (11) 2 394 663 A1<br />

(25) En (26) En<br />

(21) 10382153.4 (22) 31.05.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(54) • Zusammensetzungen für injizierbare, insitu<br />

biologisch abbaubare Implantate<br />

• Compositions for injectable in-situ biodegradable<br />

implants<br />

• Compositions pour implants biodégradables<br />

in situ injectables<br />

(71) LABORATORIOS FARMACEUTICOS ROVI, S.<br />

A., c/Julián Camarillo, 35, 28037 Madrid, ES<br />

(72) Guierro Aduriz, Ibon, 28037, Madrid, ES<br />

Gomez Ochoa, María Teresa, 28037, Madrid,<br />

ES<br />

(74) Elzaburu Marquez, Alberto, et al, ELZABURU<br />

S.L.P. C/ Miguel Angel, 21, 2º, 28010<br />

Madrid, ES<br />

(51) A61K 47/34 (11) 2 394 664 A1<br />

(25) En (26) En<br />

(21) 10382154.2 (22) 31.05.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(54) • Zusammensetzungen für injizierbare, insitu<br />

biologisch abbaubare Implantate<br />

• Antipsychotic injectable depot composition<br />

• Compositions pour implants biodégradables<br />

in situ injectables<br />

(71) LABORATORIOS FARMACEUTICOS ROVI, S.<br />

A., c/Julián Camarillo, 35, 28037 Madrid, ES<br />

(72) Gutierro Aduriz, Ibon, 28037, Madrid, ES<br />

Gomez Ochoa, María Teresa, 28037, Madrid,<br />

ES<br />

(74) Elzaburu Marquez, Alberto, et al, ELZABURU<br />

S.L.P. C/ Miguel Angel, 21, 2º, 28010<br />

Madrid, ES

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!